Skip Navigation

Max Kates, M.D.

Max Reuben Kates, M.D.

Headshot of Max Kates
4.9out of 5
141 Ratings
  • Director, Bladder Cancer Program
  • Associate Professor of Urology


Benign Prostatic Hyperplasia (BPH), Bladder Cancer, Kidney Cancer, Penile Cancer, Prostate Cancer, Robotic Cystectomy, Robotic Nephrectomy, Robotic Partial Nephrectomy, Robotic Prostatectomy, Robotic Surgery, Testicular Cancer more

Request an Appointment

Insurance Information

Main Phone

Outside of Maryland & Washington D.C.

Request Appointment

International Patients

Request Appointment


The Johns Hopkins Hospital

Appointment Phone: 410-955-6100
600 N. Wolfe Street
Baltimore, MD 21287 map

Johns Hopkins Medicine - Green Spring Station

Appointment Phone: 410-955-6100
10803 Falls Road
Pavilion III, Suite 3300
Lutherville, MD 21093 map
Phone: 410-616-7600


Dr. Max Kates is an Associate Professor of Urology and Oncology in the Brady Urological Institute. Dr. Kates received his undergraduate degree from Wesleyan University in Connecticut, and his medical degree from Mount Sinai School of Medicine in New York. During that time he completed a Doris Duke clinical research fellowship in Urologic Oncology at Columbia University, College of Physicians and Surgeons.

Dr. Kates has expertise in all areas of urologic oncology, including prostate, bladder, kidney, testicular, and genital cancers. With training in open, endoscopic, and robotic surgical approaches, Dr. Kates’ surgical philosophy is to assess the unique needs of each patient, and develop the right treatment plan for their malignancy. He is very hands on in his approach in the clinic and the operating room, and believes open communication with the patient, the patient’s family, and referring providers is key to ensuring a speedy recovery. 

As the clinical director of the bladder cancer multidisciplinary clinic, Dr. Kates works with the team at the Johns Hopkins Greenberg Bladder Cancer Institute to deliver a personalized approach to bladder cancer utilizing cutting edge precision medicine approaches.

Dr. Kates’ research interest parallel his clinical practice, with an emphasis on novel treatments for cancers of the urinary tract. He has a particular interest in developing novel therapies for bladder cancer, and currently has a provisional patent for a novel intravesical chemotherapy he developed with nano-engineer collaborators. Additionally, Dr. Kates has made important discoveries into the mechanism of action of intravesical BCG, the most common treatment for bladder cancer.

Dr. Kates has authored more than 70 journal articles in the fields of bladder, prostate, and kidney cancer. He has won numerous awards, including the American Urologic Association (AUA) Russell Scott Award, best poster awards from the society of urologic oncology and AUA, and best reviewer from the journal Urologic Oncology. 

To inquire about an appointment or make a referral, Dr. Kates can be contacted by phone (410) 614-0009. more


  • Director, Bladder Cancer Program
  • Associate Professor of Urology
  • Associate Professor of Oncology

Departments / Divisions

Centers & Institutes



  • MD; Mount Sinai School of Medicine (2012)


  • Urology; Johns Hopkins University School of Medicine (2018)

Board Certifications

  • American Board of Urology (Urology) (2022)

Research & Publications

Selected Publications

View all on PubMed

Dr. Kates has more than 90 publications in peer-reviewed journals. Please click the following link to access Dr. Kates' published research:

Activities & Honors


  • Finalist, Truman Scholar, 2005
  • Team Captain, Wood Memorial Award, Wesleyan University Tennis Team, 2006
  • Medical Student Training in Aging Research (MSTAR) Scholar, 2009
  • Alpha Omega Alpha (AΩA) Honor Medical Society, Mount Sinai School of Medicine, 2011
  • Gold Humanism Honor Society, Mount Sinai School of Medicine, 2011
  • Oral Presentation Award, Mount Sinai Medical Student Research Day, 2011
  • Distinction in Research, Mount Sinai School of Medicine, 2012
  • Harold Lamport Biomedical Research Award, 2012
  • Johns Hopkins Walter and Lucille Rubin Research Award, 2014
  • AUA Urology Care Foundation Russell W Scott Resident Scholar, 2015
  • Johns Hopkins Septembeard Research Scholar Award, 2015
  • Bladder Cancer Advocacy Network (BCAN) John Quale Travel Fellow, 2015
  • Mid-Atlantic AUA Resident Essay Prize, 2016
  • Society of Urologic Oncology Annual Meeting 1st prize Poster Award, 2016
  • Best Reviewer Urologic Oncology: Seminars and Original Investigations, 2016
  • Best Reviewer Urologic Oncology: Seminars and Original Investigations, 2017
  • American Urological Association Annual Meeting 1st prize Poster Award, 2018

Videos & Media

Play Video:

Bladder Cancer Advocacy Network Virtual Summit: New Developments Panel

Recent News Articles and Media Coverage

Podcast: What Are Biomarkers and Why Do They Matter to Bladder Cancer Patients? 

Recorded February 22, 2022 


Podcast: Bladder Cancer

Recorded February 2, 2022

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • 5.0 Provider Explained Things Clearly
  • 4.9 Provider Listened Carefully
  • 4.7 Provider Knew Medical History
  • 5.0 Provider Showed Respect
  • 4.8 Provider Spent Enough Time
  • 4.8 Overall Rating by Patient


4.9 out of 5 (141 Ratings, 51 Comments)
    Is this you? Edit Profile
    back to top button